242 related articles for article (PubMed ID: 15039215)
21. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.
Pierce EA; Foley ED; Smith LE
Arch Ophthalmol; 1996 Oct; 114(10):1219-28. PubMed ID: 8859081
[TBL] [Abstract][Full Text] [Related]
22. COX-2 inhibition and retinal angiogenesis in a mouse model of retinopathy of prematurity.
Wilkinson-Berka JL; Alousis NS; Kelly DJ; Gilbert RE
Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):974-9. PubMed ID: 12601017
[TBL] [Abstract][Full Text] [Related]
23. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF.
Benjamin LE; Hemo I; Keshet E
Development; 1998 May; 125(9):1591-8. PubMed ID: 9521897
[TBL] [Abstract][Full Text] [Related]
24. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms.
Erber R; Thurnher A; Katsen AD; Groth G; Kerger H; Hammes HP; Menger MD; Ullrich A; Vajkoczy P
FASEB J; 2004 Feb; 18(2):338-40. PubMed ID: 14657001
[TBL] [Abstract][Full Text] [Related]
25. Gamma-Secretase Inhibitor, DAPT, Prevents the Development of Retinopathy of Prematurity in a Rat Model by Regulating the Delta-Like Ligand 4/Notch Homolog-1 (DLL4/Notch-1) Pathway.
Sun W; Li J; Li Y; Zheng J; Zhang X; Huang X; Li S
Med Sci Monit; 2019 Jan; 25():492-499. PubMed ID: 30652694
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
Rauniyar RK; Suzuma K; King AL; Aiello LP; King GL
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):503-9. PubMed ID: 11818397
[TBL] [Abstract][Full Text] [Related]
27. Changes in components of the neurovascular unit in the retina in a rat model of retinopathy of prematurity.
Nakano A; Kondo R; Kaneko Y; Arima S; Asano D; Morita A; Sakamoto K; Nagamitsu T; Nakahara T
Cell Tissue Res; 2020 Mar; 379(3):473-486. PubMed ID: 31788758
[TBL] [Abstract][Full Text] [Related]
28. Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease.
Hartnett ME; Martiniuk D; Byfield G; Geisen P; Zeng G; Bautch VL
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3107-14. PubMed ID: 18378573
[TBL] [Abstract][Full Text] [Related]
29. Increased angiogenic factors associated with peripheral avascular retina and intravitreous neovascularization: a model of retinopathy of prematurity.
Budd SJ; Hartnett ME
Arch Ophthalmol; 2010 May; 128(5):589-95. PubMed ID: 20457980
[TBL] [Abstract][Full Text] [Related]
30. Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity.
Geisen P; Peterson LJ; Martiniuk D; Uppal A; Saito Y; Hartnett ME
Mol Vis; 2008 Feb; 14():345-57. PubMed ID: 18334951
[TBL] [Abstract][Full Text] [Related]
31. Neuronal and glial cell changes are determined by retinal vascularization in retinopathy of prematurity.
Downie LE; Pianta MJ; Vingrys AJ; Wilkinson-Berka JL; Fletcher EL
J Comp Neurol; 2007 Oct; 504(4):404-17. PubMed ID: 17663451
[TBL] [Abstract][Full Text] [Related]
32. Combined VEGF and PDGF inhibition for neovascular AMD: anti-angiogenic properties of axitinib on human endothelial cells and pericytes in vitro.
Siedlecki J; Wertheimer C; Wolf A; Liegl R; Priglinger C; Priglinger S; Eibl-Lindner K
Graefes Arch Clin Exp Ophthalmol; 2017 May; 255(5):963-972. PubMed ID: 28161830
[TBL] [Abstract][Full Text] [Related]
33. Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP.
Budd S; Byfield G; Martiniuk D; Geisen P; Hartnett ME
Exp Eye Res; 2009 Nov; 89(5):718-27. PubMed ID: 19576214
[TBL] [Abstract][Full Text] [Related]
34. Variable oxygen and retinal VEGF levels: correlation with incidence and severity of pathology in a rat model of oxygen-induced retinopathy.
Werdich XQ; McCollum GW; Rajaratnam VS; Penn JS
Exp Eye Res; 2004 Nov; 79(5):623-30. PubMed ID: 15500821
[TBL] [Abstract][Full Text] [Related]
35. A role for VEGF as a negative regulator of pericyte function and vessel maturation.
Greenberg JI; Shields DJ; Barillas SG; Acevedo LM; Murphy E; Huang J; Scheppke L; Stockmann C; Johnson RS; Angle N; Cheresh DA
Nature; 2008 Dec; 456(7223):809-13. PubMed ID: 18997771
[TBL] [Abstract][Full Text] [Related]
36. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats.
Fernandez M; Mejias M; Garcia-Pras E; Mendez R; Garcia-Pagan JC; Bosch J
Hepatology; 2007 Oct; 46(4):1208-17. PubMed ID: 17654489
[TBL] [Abstract][Full Text] [Related]
37. A plasticity for blood vessel remodeling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF.
Gendron RL
Surv Ophthalmol; 1999; 44(2):184-5. PubMed ID: 10541158
[No Abstract] [Full Text] [Related]
38. Genetic inactivation of the adenosine A2A receptor attenuates pathologic but not developmental angiogenesis in the mouse retina.
Liu XL; Zhou R; Pan QQ; Jia XL; Gao WN; Wu J; Lin J; Chen JF
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6625-32. PubMed ID: 20610844
[TBL] [Abstract][Full Text] [Related]
39. The selective class III/V receptor tyrosine kinase inhibitor SU11657 inhibits tumor growth and angiogenesis in experimental neuroblastomas grown in mice.
Bäckman U; Christofferson R
Pediatr Res; 2005 May; 57(5 Pt 1):690-5. PubMed ID: 15718357
[TBL] [Abstract][Full Text] [Related]
40. Relationship between Pericytes and Endothelial Cells in Retinal Neovascularization: A Histological and Immunofluorescent Study of Retinal Angiogenesis.
Choi SH; Chung M; Park SW; Jeon NL; Kim JH; Yu YS
Korean J Ophthalmol; 2018 Feb; 32(1):70-76. PubMed ID: 29376221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
